A network focused on researching unmet clinical needs in both children and adults, known as rare congenital and acquired diseases, such as monogenic diseases, cancer, and inflammatory/autoimmune diseases. Its objective is to promote the development of advanced therapy medicinal products (ATMPs) that can be transferred to society once scientifically validated.

Website: REDTERAV (under construction)